These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14607494)

  • 1. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
    Crotti TN; Smith MD; Findlay DM; Zreiqat H; Ahern MJ; Weedon H; Hatzinikolous G; Capone M; Holding C; Haynes DR
    Biomaterials; 2004 Feb; 25(4):565-73. PubMed ID: 14607494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
    Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V
    Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.
    Grimaud E; Soubigou L; Couillaud S; Coipeau P; Moreau A; Passuti N; Gouin F; Redini F; Heymann D
    Am J Pathol; 2003 Nov; 163(5):2021-31. PubMed ID: 14578201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct gene expression of receptor activator of nuclear factor-kappaB and rank ligand in the inflammatory response to variant morphologies of UHMWPE particles.
    Ren W; Yang SY; Fang HW; Hsu S; Wooley PH
    Biomaterials; 2003 Nov; 24(26):4819-26. PubMed ID: 14530078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis.
    Haynes DR; Crotti TN; Potter AE; Loric M; Atkins GJ; Howie DW; Findlay DM
    J Bone Joint Surg Br; 2001 Aug; 83(6):902-11. PubMed ID: 11521937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone lysis and inflammation.
    Haynes DR
    Inflamm Res; 2004 Nov; 53(11):596-600. PubMed ID: 15693607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
    Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles.
    Masui T; Sakano S; Hasegawa Y; Warashina H; Ishiguro N
    Biomaterials; 2005 May; 26(14):1695-702. PubMed ID: 15576143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants.
    Holding CA; Findlay DM; Stamenkov R; Neale SD; Lucas H; Dharmapatni AS; Callary SA; Shrestha KR; Atkins GJ; Howie DW; Haynes DR
    Biomaterials; 2006 Oct; 27(30):5212-9. PubMed ID: 16806459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
    Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
    J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
    Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
    J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
    Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
    J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis.
    Crotti T; Smith MD; Hirsch R; Soukoulis S; Weedon H; Capone M; Ahern MJ; Haynes D
    J Periodontal Res; 2003 Aug; 38(4):380-7. PubMed ID: 12828654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement.
    Mandelin J; Li TF; Liljeström M; Kroon ME; Hanemaaijer R; Santavirta S; Konttinen YT
    J Bone Joint Surg Br; 2003 Nov; 85(8):1196-201. PubMed ID: 14653607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
    Evans CE; Mylchreest S; Andrew JG
    BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.
    Swanson C; Lorentzon M; Conaway HH; Lerner UH
    Endocrinology; 2006 Jul; 147(7):3613-22. PubMed ID: 16614077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of osteoclast activity in peri-implant tissues.
    Haynes DR; Crotti TN; Zreiqat H
    Biomaterials; 2004 Sep; 25(20):4877-85. PubMed ID: 15109848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation.
    Mandelin J; Liljeström M; Li TF; Ainola M; Hukkanen M; Salo J; Santavirta S; Konttinen YT
    J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):582-8. PubMed ID: 15768436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.
    Haynes DR; Crotti TN; Loric M; Bain GI; Atkins GJ; Findlay DM
    Rheumatology (Oxford); 2001 Jun; 40(6):623-30. PubMed ID: 11426018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.